ℹ️
🇬🇧
Search
Search for people relevant for "comparison"
comparison
Person
Class
Person
Publication
Programmes
Export current view
PharmDr. Eliška Potůčková Ph.D.
External person at Faculty of Pharmacy in Hradec Králové
27 publications
Publications
publication
Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents
2015 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury
2010 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury
2010 |
Central Library of Charles University
publication
Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy
2023 |
Second Faculty of Medicine, Faculty of Science
publication
Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL
2023 |
Central Library of Charles University, Second Faculty of Medicine
publication
Frequency and prognostic impact of ZEB2 H1038 and 1072 mutations in childhood B-other acute lymphoblastic leukemia
2021 |
Second Faculty of Medicine
publication
Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation
2020 |
Second Faculty of Medicine
publication
ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity
2019 |
Second Faculty of Medicine
Load more publications (17)
Loading network view...